(Q83824834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

meta-analysis

0 references

title

Cetuximab-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of K-ras mutations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

metastatic colon cancer

1 reference

Ezzeldin M Ibrahim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jamal M Zekri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Bakr M Bin Sadiq

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

23 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Colorectal Disease

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

713-721

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20309588%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00384-010-0927-4

28 January 2020

exact match

0 references

cites work

Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha

1 reference

12 December 2020

Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials

1 reference

12 December 2020

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy

1 reference

12 December 2020

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

12 December 2020

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

1 reference

12 December 2020

Treatment in advanced colorectal cancer: what, when and how?

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas

1 reference

12 December 2020

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients

1 reference

12 December 2020

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

1 reference

12 December 2020

Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.

1 reference

12 December 2020

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

1 reference

12 December 2020

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

12 December 2020

Cetuximab for the treatment of colorectal cancer.

1 reference

12 December 2020

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

1 reference

12 December 2020

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

1 reference

12 December 2020

A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

1 reference

12 December 2020

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

1 reference

12 December 2020

Bias in meta-analysis detected by a simple, graphical test

1 reference

12 December 2020

Genetic alterations during colorectal-tumor development

1 reference

12 December 2020

EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

1 reference

12 December 2020

Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system

1 reference

12 December 2020

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

1 reference

12 December 2020

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

12 December 2020

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

12 December 2020

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

12 December 2020

Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer

1 reference

12 December 2020

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

12 December 2020

Quantitative synthesis in systematic reviews

1 reference

12 December 2020